tiprankstipranks
Trending News
More News >
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Financial Statements

Compare
112 Followers

BioNexus Gene Lab Corp Financial Overview

BioNexus Gene Lab Corp's market cap is currently $7.37M. The company's EPS TTM is $-0.888; its P/E ratio is -3.21; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

BioNexus Gene Lab Corp Debt to Assets

BioNexus Gene Lab Corp Cash Flow

BioNexus Gene Lab Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.